ArticleThe pharmacogenomics journal2018

Confirmation of an IRAK3 polymorphism as a genetic marker predicting response to anti-TNF treatment in rheumatoid arthritis.

J Sode et al.PubMed ↗Publisher ↗

No numbers read from the abstract.